Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2017 by GeneCure Biotechnologies
Sponsor:
Information provided by (Responsible Party):
GeneCure Biotechnologies
ClinicalTrials.gov Identifier:
NCT01428596
First received: September 1, 2011
Last updated: April 21, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):